B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SENP1

MOLECULAR TARGET

SUMO specific peptidase 1

UniProt: Q9P0U3NCBI Gene: 298435 compounds

SENP1 (SUMO specific peptidase 1) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SENP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1pomolic acid2.7114
2vialinin a1.956
3Ursolic Acid1.393
4streptonigrin1.102
5Ethylmaleimide0.691

About SENP1 as a Drug Target

SENP1 (SUMO specific peptidase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented SENP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SENP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.